vs

Side-by-side financial comparison of AWARE INC (AWRE) and VSEE HEALTH, INC. (VSEE). Click either name above to swap in a different company.

VSEE HEALTH, INC. is the larger business by last-quarter revenue ($3.9M vs $3.4M, roughly 1.2× AWARE INC). On growth, VSEE HEALTH, INC. posted the faster year-over-year revenue change (5.1% vs -6.2%). Over the past eight quarters, VSEE HEALTH, INC.'s revenue compounded faster (55.6% CAGR vs -11.5%).

AWARE Inc. is a technology firm specializing in biometric software and identity verification solutions. It develops fingerprint, facial, and iris recognition tools, serving government agencies, financial institutions, and enterprise clients primarily across North America and global regulated markets.

VSEE HEALTH, INC. is a US-based telehealth technology firm offering HIPAA-compliant virtual care platforms, remote consultation tools, and chronic disease management solutions. It primarily serves healthcare providers, enterprise clients and nonprofits across North America and select global markets.

AWRE vs VSEE — Head-to-Head

Bigger by revenue
VSEE
VSEE
1.2× larger
VSEE
$3.9M
$3.4M
AWRE
Growing faster (revenue YoY)
VSEE
VSEE
+11.3% gap
VSEE
5.1%
-6.2%
AWRE
Faster 2-yr revenue CAGR
VSEE
VSEE
Annualised
VSEE
55.6%
-11.5%
AWRE

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
AWRE
AWRE
VSEE
VSEE
Revenue
$3.4M
$3.9M
Net Profit
$-7.9M
Gross Margin
90.1%
46.7%
Operating Margin
-107.8%
-87.6%
Net Margin
-200.0%
Revenue YoY
-6.2%
5.1%
Net Profit YoY
-144.7%
EPS (diluted)
$-0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AWRE
AWRE
VSEE
VSEE
Q1 26
$3.4M
Q4 25
$4.7M
$3.9M
Q3 25
$5.1M
$4.0M
Q2 25
$3.9M
$3.4M
Q1 25
$3.6M
$3.3M
Q4 24
$4.8M
$3.7M
Q3 24
$3.8M
$3.4M
Q2 24
$4.3M
$1.7M
Net Profit
AWRE
AWRE
VSEE
VSEE
Q1 26
Q4 25
$-1.5M
$-7.9M
Q3 25
$-1.1M
$-289.7K
Q2 25
$-1.8M
$-2.6M
Q1 25
$-1.6M
$-4.0M
Q4 24
$-1.2M
$-3.2M
Q3 24
$-1.2M
$-53.9M
Q2 24
$-1.1M
$-634.1K
Gross Margin
AWRE
AWRE
VSEE
VSEE
Q1 26
90.1%
Q4 25
94.7%
46.7%
Q3 25
90.4%
52.1%
Q2 25
91.3%
46.9%
Q1 25
93.2%
56.0%
Q4 24
99.6%
63.8%
Q3 24
93.0%
83.0%
Q2 24
93.8%
45.4%
Operating Margin
AWRE
AWRE
VSEE
VSEE
Q1 26
-107.8%
Q4 25
-31.1%
-87.6%
Q3 25
-25.2%
-51.7%
Q2 25
-50.3%
-66.5%
Q1 25
-51.3%
-55.1%
Q4 24
-30.7%
-81.1%
Q3 24
-38.1%
-1737.8%
Q2 24
-31.0%
-54.5%
Net Margin
AWRE
AWRE
VSEE
VSEE
Q1 26
Q4 25
-31.2%
-200.0%
Q3 25
-20.5%
-7.3%
Q2 25
-45.4%
-77.1%
Q1 25
-44.3%
-119.2%
Q4 24
-24.8%
-85.9%
Q3 24
-30.3%
-1607.5%
Q2 24
-25.2%
-37.0%
EPS (diluted)
AWRE
AWRE
VSEE
VSEE
Q1 26
Q4 25
$-0.07
$-0.31
Q3 25
$-0.05
$-0.02
Q2 25
$-0.08
$-0.16
Q1 25
$-0.08
$-0.24
Q4 24
$-0.05
$-1.96
Q3 24
$-0.06
$-3.58
Q2 24
$-0.05
$-0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AWRE
AWRE
VSEE
VSEE
Cash + ST InvestmentsLiquidity on hand
$4.6M
$5.3M
Total DebtLower is stronger
$2.7M
Stockholders' EquityBook value
$5.5M
Total Assets
$33.2M
$22.4M
Debt / EquityLower = less leverage
0.50×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AWRE
AWRE
VSEE
VSEE
Q1 26
$4.6M
Q4 25
$7.3M
$5.3M
Q3 25
$6.3M
$472.8K
Q2 25
$7.3M
$291.6K
Q1 25
$8.5M
$410.1K
Q4 24
$13.0M
$326.1K
Q3 24
$11.2M
$2.3M
Q2 24
$11.5M
$1.1M
Total Debt
AWRE
AWRE
VSEE
VSEE
Q1 26
Q4 25
$2.7M
Q3 25
$3.4M
Q2 25
$3.0M
Q1 25
$2.6M
Q4 24
$1.9M
Q3 24
$1.9M
Q2 24
$2.4M
Stockholders' Equity
AWRE
AWRE
VSEE
VSEE
Q1 26
Q4 25
$26.1M
$5.5M
Q3 25
$27.2M
$-5.6M
Q2 25
$28.1M
$-5.7M
Q1 25
$29.5M
$-3.5M
Q4 24
$30.9M
$-18.5K
Q3 24
$31.9M
$933.1K
Q2 24
$32.6M
$53.1M
Total Assets
AWRE
AWRE
VSEE
VSEE
Q1 26
$33.2M
Q4 25
$37.2M
$22.4M
Q3 25
$40.3M
$18.7M
Q2 25
$38.1M
$18.2M
Q1 25
$39.9M
$19.4M
Q4 24
$42.6M
$20.0M
Q3 24
$43.7M
$22.3M
Q2 24
$43.2M
$78.6M
Debt / Equity
AWRE
AWRE
VSEE
VSEE
Q1 26
Q4 25
0.50×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
2.08×
Q2 24
0.05×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AWRE
AWRE
VSEE
VSEE
Operating Cash FlowLast quarter
$-1.9M
Free Cash FlowOCF − Capex
$-1.9M
FCF MarginFCF / Revenue
-49.2%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-3.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AWRE
AWRE
VSEE
VSEE
Q1 26
Q4 25
$1.0M
$-1.9M
Q3 25
$-2.4M
$-754.5K
Q2 25
$-1.2M
$-324.6K
Q1 25
$-2.9M
$-440.5K
Q4 24
$683.0K
$-3.0M
Q3 24
$-765.0K
$-221.0K
Q2 24
$-668.0K
$-3.2M
Free Cash Flow
AWRE
AWRE
VSEE
VSEE
Q1 26
Q4 25
$926.0K
$-1.9M
Q3 25
$-761.8K
Q2 25
$-328.2K
Q1 25
$-3.0M
$-452.4K
Q4 24
$-3.0M
Q3 24
$-226.0K
Q2 24
$-3.2M
FCF Margin
AWRE
AWRE
VSEE
VSEE
Q1 26
Q4 25
19.9%
-49.2%
Q3 25
-19.1%
Q2 25
-9.7%
Q1 25
-82.7%
-13.6%
Q4 24
-79.8%
Q3 24
-6.7%
Q2 24
-187.6%
Capex Intensity
AWRE
AWRE
VSEE
VSEE
Q1 26
Q4 25
2.6%
0.2%
Q3 25
0.0%
0.2%
Q2 25
0.0%
0.1%
Q1 25
1.2%
0.4%
Q4 24
0.1%
Q3 24
0.0%
0.1%
Q2 24
2.1%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AWRE
AWRE

Segment breakdown not available.

VSEE
VSEE

Professional Services And Other Fees$3.1M79%
Other$823.2K21%

Related Comparisons